Загрузка...
RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION
Aim. To assess effectiveness and safety of the hospital use of recombinant non-immunogenic staphylokinase in patients with acute ST-elevated myocardial infarction (STEMI).Material and methods. Recombinant non-immunogenic staphylokinase was administered during in-hospital stage of treatment of 93 pa...
Сохранить в:
Главный автор: | |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Stolichnaya Izdatelskaya Kompaniya
2017-03-01
|
Серии: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Предметы: | |
Online-ссылка: | https://www.rpcardio.com/jour/article/view/1416 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|